Compass Pathways
Founded Year
2016Stage
PIPE | IPOTotal Raised
$113MMarket Cap
0.40BStock Price
6.45About Compass Pathways
Compass Pathways (NASDAQ: CMPS) operates as a pharmaceutical company. It develops the active substance psilocybin for the treatment of patients with treatment-resistant depression. The company was founded in 2016 and is based in Altrincham, U.K.
Loading...
Loading...
Research containing Compass Pathways
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Compass Pathways in 2 CB Insights research briefs, most recently on May 3, 2023.
Expert Collections containing Compass Pathways
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Compass Pathways is included in 2 Expert Collections, including Psychedelics.
Psychedelics
329 items
Game Changers 2018
36 items
Our selected startups are high-momentum companies pioneering technology with the potential to transform society and economies for the better.
Compass Pathways Patents
Compass Pathways has filed 3 patents.
The 3 most popular patent topics include:
- entheogens
- psilocybe
- psychedelic tryptamine carriers
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/8/2019 | 11/22/2022 | Psychoactive fungi, Psychedelic tryptamine carriers, Entheogens, Psilocybe, Psychiatric diagnosis | Grant |
Application Date | 11/8/2019 |
|---|---|
Grant Date | 11/22/2022 |
Title | |
Related Topics | Psychoactive fungi, Psychedelic tryptamine carriers, Entheogens, Psilocybe, Psychiatric diagnosis |
Status | Grant |
Latest Compass Pathways News
Nov 27, 2023
Green Market Report had a chance to sit down with Rock Feilding-Mellen to discuss the recent capital raise by Beckley Waves. The company is focused on building its academy to help train therapists in psychedelic drug treatments. The company believes that when MDMA is approved for Compass Pathways, there will be a huge need for […] The cannabis industry has proven over time that planting a flag in a new adult-use state pays off handsomely. For MSOs that chose wisely; New Jersey helped boost top-line sales in 2022 and this year it was the companies that staked a claim in Maryland. The pent-up demand in those states along with sales from […] In other news Green Market Report had a chance to sit down with Rock Feilding-Mellen to discuss the recent capital raise by Beckley Waves . The company is focused on building its academy to help train therapists in psychedelic drug treatments. The company believes that when MDMA is approved for Compass Pathways, there will be a huge need for these specially trained professionals. Video Staff
Compass Pathways Frequently Asked Questions (FAQ)
When was Compass Pathways founded?
Compass Pathways was founded in 2016.
Where is Compass Pathways's headquarters?
Compass Pathways's headquarters is located at 3rd Floor, 1 Ashley Road, Altrincham.
What is Compass Pathways's latest funding round?
Compass Pathways's latest funding round is PIPE.
How much did Compass Pathways raise?
Compass Pathways raised a total of $113M.
Who are the investors of Compass Pathways?
Investors of Compass Pathways include Soleus Capital Management, Surveyor Capital, RA Capital Advisors, Vivo Capital, PFM Health Sciences and 21 more.
Who are Compass Pathways's competitors?
Competitors of Compass Pathways include Nue Life and 4 more.
Loading...
Compare Compass Pathways to Competitors
Journey Clinical is a health technology company focusing on the mental health sector. The company provides a platform for psychotherapists to offer ketamine-assisted psychotherapy (KAP), a treatment modality that combines the use of ketamine with psychotherapy for conditions such as depression, anxiety, and post-traumatic stress disorder (PTSD). Journey Clinical primarily serves the mental health industry. It was founded in 2020 and is based in New York, New York.
Curio offers mental health virtual clinic for ketamine treatment. The company offers psychedelic-assisted coaching and therapy (PACT) to feel better without daily pills. It serves individuals, health clinics, and health systems. It was founded in 2020 and is based in Glendale, New York.
Mindbloom operates as a mental health and well-being company. It provides science-backed mental health research and provides health and well-being treatments specifically through ketamine therapy for depression and anxiety. The company was founded in 2018 and is based in Orlando, Florida.
Tryp Therapeutics (CNSX: TRYP) is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. Its main development program PFN program is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. The company was founded in 2019 and is based in San Diego, California.
Neural Therapeutics is a drug-discovery company focusing on plant-based active substances. It manufactures over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. The company was founded in 2023 and is based in Toronto, Canada.
Clairvoyant Therapeutics is a biotechnology company focused on short path clinical trial speed to market strategy for psilocybin psycho-assisted therapy. The company was founded in 2021 and is based in Vancouver Canada.
Loading...